Some weight regain is common if the medication is stopped without building sustainable habits during treatment
65 However, a controlled, randomized, double-blind, multicenter study assessing the safety, tolerability, pharmacokinetics, and efficacy of nidufexor in patients with MASH was terminated without results posted (NCT02913105)
This form of carnitine is uniquely characterised by the presence of an acetyl group , which facilitates the absorption of the molecule in the intestine, allowing it to cross the blood-brain barrier, the protective barrier separating the bloodstream from the brain
Comparative discussions around GLP-1 medications often center on differences in efficacy, dosing convenience, and metabolic impact
What We Know
Most adverse events were mild to moderate gastrointestinal events, primarily occurring during the dose-escalation period